全文获取类型
收费全文 | 4802篇 |
免费 | 394篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 156篇 |
妇产科学 | 173篇 |
基础医学 | 733篇 |
口腔科学 | 54篇 |
临床医学 | 578篇 |
内科学 | 839篇 |
皮肤病学 | 111篇 |
神经病学 | 441篇 |
特种医学 | 99篇 |
外科学 | 310篇 |
综合类 | 58篇 |
一般理论 | 6篇 |
预防医学 | 629篇 |
眼科学 | 69篇 |
药学 | 526篇 |
中国医学 | 2篇 |
肿瘤学 | 406篇 |
出版年
2023年 | 39篇 |
2022年 | 62篇 |
2021年 | 101篇 |
2020年 | 74篇 |
2019年 | 129篇 |
2018年 | 124篇 |
2017年 | 96篇 |
2016年 | 146篇 |
2015年 | 120篇 |
2014年 | 205篇 |
2013年 | 266篇 |
2012年 | 384篇 |
2011年 | 353篇 |
2010年 | 187篇 |
2009年 | 187篇 |
2008年 | 288篇 |
2007年 | 353篇 |
2006年 | 305篇 |
2005年 | 311篇 |
2004年 | 288篇 |
2003年 | 227篇 |
2002年 | 275篇 |
2001年 | 45篇 |
2000年 | 35篇 |
1999年 | 45篇 |
1998年 | 59篇 |
1997年 | 42篇 |
1996年 | 45篇 |
1995年 | 33篇 |
1994年 | 35篇 |
1993年 | 33篇 |
1992年 | 13篇 |
1991年 | 25篇 |
1990年 | 11篇 |
1989年 | 18篇 |
1988年 | 14篇 |
1987年 | 19篇 |
1986年 | 10篇 |
1985年 | 15篇 |
1984年 | 9篇 |
1983年 | 10篇 |
1982年 | 20篇 |
1981年 | 15篇 |
1980年 | 15篇 |
1978年 | 9篇 |
1977年 | 9篇 |
1975年 | 8篇 |
1974年 | 10篇 |
1973年 | 10篇 |
1971年 | 8篇 |
排序方式: 共有5202条查询结果,搜索用时 15 毫秒
61.
Martin Stroedicke Yacine Bounab Nadine Strempel Konrad Klockmeier Sargon Yigit Ralf P. Friedrich Gautam Chaurasia Shuang Li Franziska Hesse Sean-Patrick Riechers Jenny Russ Cecilia Nicoletti Annett Boeddrich Thomas Wiglenda Christian Haenig Sigrid Schnoegl David Fournier Rona K. Graham Michael R. Hayden Stephan Sigrist Gillian P. Bates Josef Priller Miguel A. Andrade-Navarro Matthias E. Futschik Erich E. Wanker 《Genome research》2015,25(5):701-713
62.
Gillian Ray-Barruel Amanda J. Ullman Claire M. Rickard Marie Cooke 《Australian critical care》2018,31(2):106-109
Clinical audits are an essential part of the cycle designed to ensure that patients receive the best quality of care. By measuring the care delivered against established best practice standards, it becomes possible to identify shortcomings and to plan targeted strategies and processes for continuous improvement. The success of a clinical audit depends upon defined goals, motivation of stakeholders, appropriate tools and resources, and clear communication.In part 1 of this series, an overview of the structures and processes needed to prepare and collect data for clinical audits in the critical care setting was provided [A.J. Ullman, G. Ray-Barruel, C.M. Rickard, M. Cooke, Clinical audits to improve critical care: Part 1 Prepare and collect data, Aust Crit Care, 2017, in press]. In part 2, we discuss how to analyse the collected audit data, benchmark findings with internal and external data sets, and feedback audit results to critical care clinicians to promote evidence-based practice and improve patient outcomes. 相似文献
63.
Rebecca Hibbs PhD Charlotte Rhind MSc Laura Salerno PhD Gianluca Lo Coco PhD Elizabeth Goddard PhD Ulrike Schmidt MD PhD Nadia Micali MD PhD Simon Gowers MD PhD Jennifer Beecham PhD Pamela Macdonald PhD Gillian Todd RMN MSc Iain Campbell PhD Janet Treasure MD PhD 《The International journal of eating disorders》2015,48(3):290-297
64.
Robert D. Cannon Gillian A. Beauchamp Paige Roth Jennifer Stephens David B. Burmeister David M. Richardson Alanna M. Balbi Tennessee D. Park Stephen W. Dusza Marna Rayl Greenberg 《Clinical therapeutics》2018,40(2):197-203
Purpose
Substance use and misuse is prevalent in emergency department (ED) populations. While the prevalence of substance use and misuse is reported, sex-specific trends in ED populations have not been documented. We set out to determine the sex-specific prevalence of ED patient substance use during this current epidemic.Methods
A retrospective electronic data abstraction tool, developed for quality-improvement purposes, was used to assess ED visits in 3 hospitals in northeastern Pennsylvania. All patients with ED diagnosis codes for substance use F10.000 through F 19.999 (excluding F17 codes for nicotine) were abstracted for network ED visits at all 3 hospitals. Data points included ED clinical enrollment site, primary substance used, sex, date of ED visit, disposition (including left without being seen, left against medical advice, discharged, admitted, and treatment in rehabilitation) for 18 months (January 1, 2016 through July 31, 2017). The categorical parameters of sex, clinical enrollment site, diagnosis, date of ED visit, and disposition status were summarized as a proportion of the subject group. Time series analysis was used to assess trends in substance use and misuse visits by patient sex.Findings
A total of 10,511 patients presented to the EDs during the study time period with a final diagnosis of a substance use?related reason and were included in the analysis. The mean age for these patients was 43.6 (SD 16.4) years, and the majority was male (65.6%, n = 6900). The most common substance in the final diagnosis for the ED visit was alcohol (54.3%; 95% CI, 53.3–55.2), followed by opioids (19.2%; 95% CI, 18.4–19.9) and cannabis (14.4%; 95% CI, 13.7–15.0). Females tended to be younger than males (42.4 years vs 44.3 years; P < 0.001), and were more likely to be discharged after the ED visit than males (36.1% vs 32.3%; P < 0.001). When exploring differences in age by sex and substance, males with a final diagnosis including alcohol- and cannabis-related issues were older than females, whereas females diagnosed with opioid-related reasons were older than males (41.3 vs 38.9 years; P < 0.001).Implications
There are sex-specific differences in prevalence of patients presenting with substance use in the ED setting. 相似文献65.
Manu Shankar-Hari Deepankar Datta Julie Wilson Valentina Assi Jacqueline Stephen Christopher J. Weir Jillian Rennie Jean Antonelli Anthony Bateman Jennifer M. Felton Noel Warner Kevin Judge Jim Keenan Alice Wang Tony Burpee Alun K. Brown Sion M. Lewis Tracey Mare Alistair I. Roy John Wright Gillian Hulme Ian Dimmick Alasdair Gray Adriano G. Rossi A. John Simpson Andrew Conway Morris Timothy S. Walsh 《Intensive care medicine》2018,44(11):1836-1848
Purpose
Reliable biomarkers for predicting subsequent sepsis among patients with suspected acute infection are lacking. In patients presenting to emergency departments (EDs) with suspected acute infection, we aimed to evaluate the reliability and discriminant ability of 47 leukocyte biomarkers as predictors of sepsis (Sequential Organ Failure Assessment score?≥?2 at 24 h and/or 72 h following ED presentation).Methods
In a multi-centre cohort study in four EDs and intensive care units (ICUs), we standardised flow-cytometric leukocyte biomarker measurement and compared patients with suspected acute infection (cohort-1) with two comparator cohorts: ICU patients with established sepsis (cohort-2), and ED patients without infection or systemic inflammation but requiring hospitalization (cohort-3).Results
Between January 2014 and February 2016, we recruited 272, 59 and 75 patients to cohorts 1, 2, and 3, respectively. Of 47 leukocyte biomarkers, 14 were non-reliable, and 17 did not discriminate between the three cohorts. Discriminant analyses for predicting sepsis within cohort-1 were undertaken for eight neutrophil (cluster of differentiation antigens (CD) CD15; CD24; CD35; CD64; CD312; CD11b; CD274; CD279), seven monocyte (CD35; CD64; CD312; CD11b; HLA-DR; CD274; CD279) and a CD8 T-lymphocyte biomarker (CD279). Individually, only higher neutrophil CD279 [OR 1.78 (95% CI 1.23–2.57); P?=?0.002], higher monocyte CD279 [1.32 (1.03–1.70); P?=?0.03], and lower monocyte HLA-DR [0.73 (0.55–0.97); P?=?0.03] expression were associated with subsequent sepsis. With logistic regression the optimum biomarker combination was increased neutrophil CD24 and neutrophil CD279, and reduced monocyte HLA-DR expression, but no combination had clinically relevant predictive validity.Conclusions
From a large panel of leukocyte biomarkers, immunosuppression biomarkers were associated with subsequent sepsis in ED patients with suspected acute infection.Clinical trial registration
NCT02188992.66.
67.
Tober G 《Addiction (Abingdon, England)》2004,99(6):677-685
The Society for the Study of Addiction (SSA) is a learned society which is a company limited by guarantee with charitable status, an independent organization promoting the cause of research, public policy and treatment of addiction. Founded in London in 1884 with the aim of promoting a research-based understanding of inebriety, it is the oldest society of its kind. The pursuit and enhancement of evidence-based policy and treatment informed its work in the early days and has remained its organizing principle throughout its history. Led initially by medical political interests, the Society has grown to encompass a broader disciplinary base, reflecting the expansion of interest in addiction from biological, psychological and social science into nursing, social work, probation, other arms of criminal justice work and voluntary sector professionals. Today its membership is made up of researchers, practitioners and policy makers from all these disciplines, the majority of whom reside and work in the United Kingdom; its international membership makes up nearly one-third of the total membership and there are current endeavours to expand collaboration with other national societies in the field. Its activities are focused upon the Society journals, Addiction and Addiction Biology, other publishing activities, the annual symposium and a number of policy initiatives. 相似文献
68.
Gallego PH Shephard N Bulsara MK van Bockxmeer FM Powell BL Beilby JP Arscott G Le Page M Palmer LJ Davis EA Jones TW Choong CS 《Journal of diabetes and its complications》2008,22(3):191-198
AIM: We examined genetic polymorphisms in the renin-angiotensin system (RAS) coding for angiotensin I-converting enzyme (ACE) insertion/deletion (I/D) for angiotensinogen (AGT) M235T and angiotensin II receptor type 1 (AGTR1) A1166C as predictors for the development of microalbuminuria (MA) in children with type 1 diabetes mellitus (T1DM). METHODS: Four hundred fifty-three (215 males, 238 females) T1DM children [median (interquartile range): age, 16.7 years (13.9-18.3); diabetes duration, 6.9 years (3.3-10.8); age at diagnosis, 9.1 years (5.8-11.8)] were followed prospectively from diagnosis until the development of MA (two of three consecutive overnight urine samples with albumin excretion rates of > or =20 and <200 microg/min). Kaplan-Meier survival curves and Cox proportional multivariate model estimated the probability of developing MA and the relative risk for MA among different variables. RESULTS: MA developed in 41 (9.1%) subjects. The frequencies of genotypes were as follows: ACE-II 112 (25%), ACE-ID 221 (49%), and ACE-DD 117 (26%) (n=450); AGT-MM 144 (32%), AGT-MT 231 (51%), and AGT-TT 77 (17%) (n=452); AGTR1-AA 211 (47%), AGTR1-AC 204 (45%), and AGTR1-CC 37 (8%) (n=452). The cumulative risk for the development of MA was higher in ACE-DD versus ACE-ID/II groups (log-rank test, P=.05), and a trend was noticed when AGT-TT was compared to AGT-MT/MM groups (log-rank test, P=.08). AGT-TT polymorphism conferred a fourfold increased risk for MA compared to AGT-MM/MT (hazard ratio=3.8; 95% confidence interval=1.43-10.3; P=.008). INTERPRETATION: Our findings suggest that RAS gene polymorphism at AGT M235T is a strong predictor for early MA in young T1DM subjects. 相似文献
69.
70.
Diana Mittag Nirupama Varese Anja Scholzen Ashley Mansell Gillian Barker Gregory Rice Jennifer M. Rolland Robyn E. O'Hehir 《European journal of immunology》2013,43(3):723-733
Microbial contamination of grass pollens could affect sensitization, subsequent allergic response, and efficacy of allergen‐specific immunotherapy. We investigated whether bacterial immunomodulatory substances can direct PBMC responses of allergic and nonatopic subjects against ryegrass pollen (RGP) toward Th1, Th2, or regulatory T (Treg) cells. Aqueous extracts of RGP with high or low LPS were fractionated into large and small molecular weight (MW) components by diafiltration. CFSE‐labeled PBMCs from allergic and nonatopic subjects were stimulated with RGP extracts (RGPEs) and analyzed for cytokine secretion and T‐cell responses. High LPS RGPE increased IFN‐γ+ Th1 and IL‐4+ Th2 effector cell induction and consistently decreased CD4+Foxp3hi Treg‐cell induction. IL‐10‐producing T‐cell frequency was unaltered, but IL‐10 secretion was increased by high LPS RGPE. RGPE‐stimulation of TLR‐transfected cell lines revealed that high LPS pollen also contained a TLR2‐ligand, and both batches a TLR9‐ligand. Beta‐1,3‐glucans were detected in large and small MW fractions and were also T‐cell stimulatory. In conclusion, coexposure to allergen and proinflammatory microbial stimuli does not convert an established Th2‐ into a Th1‐response. Instead, proinflammatory responses are exacerbated and Foxp3hi Treg‐cell induction is decreased. These findings show that adjuvants for specific immunotherapy should enhance Treg cells rather than target immune deviation from Th2 to Th1. 相似文献